The Library
Microvascular complications after metabolic surgery
Tools
Tools
Tools
Dimitriadis, Georgios K., Randeva, Harpal S. and Miras, A. (2017) Microvascular complications after metabolic surgery. Lancet Diabetes and Endocrinology, 5 (4). pp. 240-241. doi:10.1016/S2213-8587(17)30042-6 ISSN 2213-8587.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: https://doi.org/10.1016/S2213-8587(17)30042-6
Abstract
Metabolic dysregulation is a defining characteristic of type 2 diabetes, which can give rise to microvascular complications—specifically retinopathy, nephropathy, and neuropathy. Increasing evidence exists from prospective studies, cases series, and national registries to show that bariatric or metabolic surgery ameliorates hyperglycaemia in people with diabetes and prevents, delays, or improves obesity-associated complications.1–3 Yet, scarce evidence exists to show the effects of surgery in patients who have not yet reached the hyperglycaemic threshold used to define diabetes.
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
